The mAbxience partnership will enable Cipla to continue its ethos of ensuring equitable access to affordable, life-saving medication
It celebrated its 100th session as LPC-100 in association with Mundial Pharma
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The focus is to build collaborative learning and sharing ecosystem
Brian joins LEO Pharma from Novo Nordisk, U.S. where he served as Senior Vice President of Sales.
The aim is to strengthen industry-academia cooperation
The cash consideration for the acquisition is US$ 18 million.
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
_256_384.jpg)
In FY21, the company reported a net profit of Rs 419 crores compared to Rs 101 crores in FY 20 and consolidated total income at Rs 6092 crores, up 19% Y-o-Y
Subscribe To Our Newsletter & Stay Updated
